RVN TIMES

Rapid Voice News

Why Calithera Biosciences Stock Is Plunging Today – Motley Fool

What happened?
Calithera Biosciences(NASDAQ:CALA), a clinical-stage biotech company, reported on Monday morning that telaglenastat, one of its leading pipeline candidates, flopped in a clinical tria… [+1639 chars]